Drug Could Improve Alzheimer's Memory Loss

Author: Elhuyar Fundazioa
Published: 2009/02/19
Topic: Alzheimer's Disease - Publications List

Page Content: Synopsis - Introduction - Main

Synopsis: A drug used in a type of hereditary metabolic disorder improved the memory of laboratory animals with Alzheimers disease.

Introduction

The research project showed that the drug sodium phenylbutyrate, prescribed until now for patients with alterations in the urea cycle, eases the fusion of proteins responsible for neuron connections, thus increasing the learning capacity of the mice involved. As a result, these discoveries offer new, promising perspectives for the treatment of Alzheimer's Disease and other related dementias.

Main Item

A drug used in a type of hereditary metabolic disorder improved the memory of laboratory animals with Alzheimer's disease. The results of the project, developed by researchers of the Center for Applied Medical Research (CIMA) of the University of Navarra have been published in the journal Neuropsychopharmacology.

The research project showed that the drug sodium phenylbutyrate, prescribed until now for patients with alterations in the urea cycle, eases the fusion of proteins responsible for neuron connections, thus increasing the learning capacity of the mice involved. As a result, these discoveries offer new, promising perspectives for the treatment of Alzheimer's Disease and other related dementias.

In addition, these findings provide a new alternative to the drugs that are currently available for fighting this devastating disease, explained Dr. Ana Garcia-Osta. Dr. Garcia-Osta is a researcher from the Department of Neurosciences and the principal author of this project.

The research team is currently focused on discovering the acting mechanism in this drug. As the drug is now clinically available and well tolerated, the confirmation of its therapeutic affectively in humans could be applied to Alzheimer's in a shorter period of time than other drugs being studied.

Alzheimer's disease is a neurodegenerative disorder associated with age and characterized by the progressive deterioration of cognitive and intellectual abilities. "Cognitive deficit is associated with a loss of neuron connections. For the memory to develop, it is necessary for a series of cellular and molecular mechanisms to be activated. The interruption of these processes affects the capacity to assimilate and store new memories, explained Dr. Garcia-Osta.

Explore Similar Topics

- Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded protein response.

- A newly found link between Alzheimer's Disease and iron could lead to new medical interventions.

Citing Information and Page References

Disabled World (DW) is a comprehensive online resource providing information and news related to disabilities, assistive technologies, and accessibility. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): Elhuyar Fundazioa. (2009, February 19). Drug Could Improve Alzheimer's Memory Loss. Disabled World (DW). Retrieved February 15, 2025 from www.disabled-world.com/health/aging/alzheimers/memory-loss-drug.php

Permalink: <a href="https://www.disabled-world.com/health/aging/alzheimers/memory-loss-drug.php">Drug Could Improve Alzheimer's Memory Loss</a>: A drug used in a type of hereditary metabolic disorder improved the memory of laboratory animals with Alzheimers disease.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.